Phase I/II study of docetaxel and S-1, an oral fluorinated pyrimidine, for untreated advanced non-small cell lung cancer
To access this article, please choose from the options below
PII: S0169-5002(09)00440-1
doi:10.1016/j.lungcan.2009.08.009
© 2009 Elsevier Ireland Ltd. All rights reserved.
